Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D67IRW
|
|||
Drug Name |
DF6002
|
|||
Drug Type |
Recombinant?protein
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199] | Phase 1/2 | [1] | |
Company |
Bristol-Myers Squibb; Dragonfly Therapeutics
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT04423029) Dose Escalation of DF6002 in Patients With Advanced Solid Tumors, and Expansion in Selected Indications. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.